Tag: investment
-
Covid-19 Antibody Developer Raises $483M in IPO
A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock.
-
Start-Up Company Creating Wearable Brain Scanner
A new enterprise, spun-off from a neuroscience lab in the U.K., is advancing a wearable scanner to detect and diagnose various brain disorders.
-
Start-Up Creating Digital Therapies for Alzheimer’s
A new enterprise is developing personalized digital therapeutics for people with Alzheimer’s disease and other neurodegenerative disorders.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Lightweight AI Chip Designer Raises $2.8M in Seed Funds
A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems.
-
Natural-Killer Cell Cancer Therapy Biotech Launches
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds.
-
Biotech Manufacturing, Distribution Company Underway
A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations.
-
Infographic – Vaccines Boost Biotech Shares
News of those trials fueled healthy share price rises for the biotechnology companies developing the vaccines, shown in this weekend’s infographic.
-
Stem Cell Respiratory Therapy Licensed in $1.4B Deal
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections.
-
Cancer Immune System Therapy Start-Up Raises $53M
A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding.